![Thomas Shepherd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Shepherd
Corporate Officer/Principal bij
CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Profiel
Thomas Shepherd currently works at Tom Shepherd Consulting SAS, as Chairman, Neurophoenix SAS, as General Director, and Captor Therapeutics SA, as Senior Vice President-Strategy from 2025.
Dr. Shepherd received his doctorate degree from the University of Strathclyde.
Actieve functies van Thomas Shepherd
| Bedrijven | Functie | Begin |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Corporate Officer/Principal | - |
Neurophoenix SAS | Algemeen Directeur | - |
Tom Shepherd Consulting SAS | Voorzitter | - |
Opleiding van Thomas Shepherd
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Captor Therapeutics SA
 Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
Neurophoenix SAS | |
Tom Shepherd Consulting SAS |
Kies MarketScreener 
